Alto Neuroscience Inc. (ANRO)

NYSE

$25.95

$-0.63

(-2.37%)

Regular Market

Alto Neuroscience Inc. (ANRO) Live Price Chart

Last updated: ⁦2026-09-30 19:11:00⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

Alto Neuroscience Inc. (ANRO) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NYSE. The stock is currently priced at $25.95, with a market capitalization of $1.05B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $3.93 to $37.48. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$1.05B
Open	$26.87
Day's High	$37.48
Day's Low	$1.60
Previous Close	$26.58
Volume	256.20K
Average Volume	539.80K
P/E Ratio	--
52-Week High	$37.48
52-Week Low	$3.93
Dividend Yield	--
Earnings Date	--

Alto Neuroscience Inc. (ANRO) Stock Price Today

Alto Neuroscience Inc. (ANRO) is currently trading at $25.95 as of 2026-09-30 19:09:00, down 2.39% ($0.63) from the previous close of $26.58

During today's regular trading session, ANRO has traded between $1.60 and $37.48, with a trading volume of 256.20K shares. The current price is near the upper end of today's range.

Alto Neuroscience Inc. (ANRO) 7-Day Stock Price Change

Over the past seven days, Alto Neuroscience Inc. (ANRO) moved from $30.63 to $25.95, representing a decline of 15.30% ($4.68).

The stock traded between $23.06 and $31.46 during the period. The latest price is near the middle of the 7-day range, indicating strong downward.

The average daily volume was 549.97 thousand shares, down versus the previous seven-day period, indicating lower trading activity.

ANRO 52-Week Price Position

Position in Range: 65.6%

52W Low$3.93

52W High$37.48

ANRO is currently trading at $25.95, placing it 65.6% of the way from its 52-week low of $3.93 to its 52-week high of $37.48. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Alto Neuroscience Inc. (ANRO)?

Alto Neuroscience Inc is a clinical-stage biopharmaceutical company with a mission to redefine psychiatry by leveraging individual's neurobiology to develop personalized and effective treatment options. The company currently consists of different clinical-stage assets such as ALTO-100, ALTO-202, ALTO-207, ALTO-101, and ALTO-300 among others initially targeting depressive disorders and schizophrenia populations as identified by independent brain-based biomarkers.

Alto Neuroscience Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	68
Exchange	NYSE
Company Website	https://www.altoneuroscience.com

How to Buy Alto Neuroscience Inc. (ANRO) Stock on MEXC

Eligible investors can buy real shares of Alto Neuroscience Inc. (ANRO) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for ANRO and Place Your Order

Open the RealStocks trading page and search for ANRO. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Alto Neuroscience Inc. (ANRO) stock price today?

Alto Neuroscience Inc. (ANRO) is currently trading at $ 25.95, down 2.39% ($0.63) from the previous close of $ 26.58. Intraday prices update in real time during regular trading hours.

2.Is ANRO stock going up or down today?

As of 2026-09-30 19:09:00, ANRO is trading at $ 25.95, down 2.39% ($0.63) from its previous close of $ 26.58. The stock has traded between $ 1.60 and $ 37.48 during today’s regular session. Past price movements do not guarantee future results.

3.What is ANRO pre-market price?

As of 2026-09-30 19:09:00, ANRO is trading at $ 27.01 in pre-market trading, up 1.61% ($0.43) from the previous close of $ 26.58. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is ANRO after-hours price?

As of 2026-09-30 19:09:00, ANRO is trading at $ 26.57 in after-hours trading, down 0.04% ($0.01) from the regular-session close of $ 26.58. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is ANRO stock trading now?

ANRO trades on the NYSE exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does ANRO sit relative to its 52-week high and low?

Over the past 52 weeks, ANRO has traded between a low of $ 3.93 and a high of $ 37.48. At $ 25.95, the stock is positioned 65.6% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Alto Neuroscience Inc. in?

Alto Neuroscience Inc. (ANRO) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Alto Neuroscience Inc.'s market capitalization and where is it listed?

Alto Neuroscience Inc. is listed on the NYSE exchange with a market capitalization of $ 1.05B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is ANRO valued in terms of P/E ratio and EPS?

ANRO trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -2.15. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Alto Neuroscience Inc. pay a dividend?

Alto Neuroscience Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.